Indivior (NASDAQ:INDV) Shares Gap Down – Here’s Why

by · The Cerbat Gem

Indivior PLC (NASDAQ:INDV – Get Free Report)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $9.52, but opened at $9.23. Indivior shares last traded at $9.45, with a volume of 114,520 shares traded.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on INDV shares. Piper Sandler reduced their target price on shares of Indivior from $16.00 to $13.00 and set an “overweight” rating on the stock in a research note on Thursday, March 6th. RODMAN&RENSHAW raised shares of Indivior to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Rodman & Renshaw initiated coverage on shares of Indivior in a research report on Tuesday, January 28th. They set a “buy” rating and a $16.00 target price for the company.

Check Out Our Latest Research Report on INDV

Indivior Price Performance

The company has a market capitalization of $1.33 billion, a P/E ratio of -27.53 and a beta of 0.82. The business’s 50-day moving average price is $10.86 and its two-hundred day moving average price is $10.56.

Indivior (NASDAQ:INDV – Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.32 earnings per share for the quarter, hitting the consensus estimate of $0.32. Indivior had a negative return on equity of 241.73% and a negative net margin of 3.96%. The firm had revenue of $298.00 million for the quarter, compared to analyst estimates of $262.35 million. Research analysts expect that Indivior PLC will post 1.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Indivior

Several large investors have recently made changes to their positions in the stock. GF Fund Management CO. LTD. bought a new position in Indivior during the 4th quarter worth about $36,000. Public Employees Retirement System of Ohio raised its holdings in shares of Indivior by 32.1% in the fourth quarter. Public Employees Retirement System of Ohio now owns 39,370 shares of the company’s stock valued at $505,000 after purchasing an additional 9,576 shares during the last quarter. Two Sigma Investments LP boosted its holdings in Indivior by 2.1% during the fourth quarter. Two Sigma Investments LP now owns 110,880 shares of the company’s stock worth $1,378,000 after purchasing an additional 2,237 shares during the last quarter. Stonepine Capital Management LLC boosted its holdings in Indivior by 13.0% during the fourth quarter. Stonepine Capital Management LLC now owns 305,000 shares of the company’s stock worth $3,791,000 after purchasing an additional 35,000 shares during the last quarter. Finally, Man Group plc increased its stake in Indivior by 291.3% in the 4th quarter. Man Group plc now owns 45,365 shares of the company’s stock valued at $564,000 after buying an additional 33,771 shares during the last quarter. Institutional investors own 60.33% of the company’s stock.

Indivior Company Profile

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

See Also